Member Info for Propinquity

I thought first gold would be poured towards the latter part of the first half of 2022 - early 2022 seems a tad unrealistically optimistic, non?

Toptuf, A fabulous red-top analogy on the outlandish predictions by some sun-seeking posters on this board.

Fira, An equally valid point.

Lupi, Indeed, it does devalue the point - unfortunately, that’s Twitter for you.

Twitterer Hursty expresses on the SML and PW Twitter accounts unadulterated criticism of the BoD - no less than deserved: after the continual lies and false promises over the past few years, how could they even expect any shareholder loyalty, let alone praise.

Kenwood tester with a PAT test - LOL.

Slurm, Agreed on the .04s’ being the floor for SML.

Dotcom, You may have a point: even though SML is not obliged to report its PEPR filing, not publicly declaring it might provoke Mr Market to temporarily drop it to the 0.4s - or even high 0.3s; which in itself would inspire collecting a few more.

No aping on this board.

Pete Wale’s Tweets are embarrassing: he continually posts about copper’s and tin’s favourably high prices - yet neither translates into any market-value for SML, primarily because two of its projects focussed on those metals have progressed very little over the past few years; as a witty Tweeter responded to one of Pete Wale’s tweets: ‘It’s all very nice having lovely presentations, but when are SML actually going to do something?’

Redkite, Second that: read Cornishknocker’s posts for rational, sensible - and articulate - analysis.

Would you think that our self-hallowed - yet evidentially incompetent - BoD will have submitted it by March 31st?

Toptuf, Indeed, a good spot; best to leave the rampers to it - and believe in your own research on a company.

VanVan, A perspicacious post that aids in preserving one’s perspective on Turkey.

Q2 onwards should prove significantly more rewarding for us unmatchably patient long-term holders - particularly for those from Keras’s antecedent, Ferrex.

Meant ‘moolah’.

Indeed, Cornish - I’m scrummaging around for more milagro.

Dr Copper certainly takes a strong fancy to the $9000 mark, settling down for while, before a strong desire for a new, higher level - patience remains vital for this one: its rapid ascent will catch many unaware, who will then rue not buying more at these levels - I wish I had more for this no-brainier of an investment.

The market will eventually rerate Amryt upwards when it decides to add up the value-enhancing RNSes of the past few months - and the other ones yet to come.

Marky, I would be interested in your entry-price - when it happens.